High-sensitivity troponin T is a prognostic marker for patients with aortic stenosis after valve replacement surgery

Journal of Cardiology

Volumn 61, Issue 5, 2013, Pages 342-347

  Saito, Toshinobu ^a   Hojo, Yukihiro ^a   Hirose, Masahiro ^a   Ikemoto, Tomokazu ^a   Katsuki, Takaaki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Heart failure; Prognosis; Troponin; Valvular heart disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; HIGH SENSITIVITY TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AORTA STENOSIS; AORTA VALVE AREA; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; FAINTNESS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART VENTRICLE PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PULMONARY ARTERY OCCLUSION PRESSURE; SEX; SUDDEN CARDIAC DEATH; THORAX PAIN;

AGED; ALLOPURINOL; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TROPONIN T;

EID: 84877594261     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.01.005     Document Type: Article

References (30)

1. Carabello B.A., Paulus W.J. Aortic stenosis. Lancet 2009, 373:956-966.
2. Ross J., Braunwald E. Aortic stenosis. Circulation 1968, 38(1 Suppl.):61-67.
3. Schwarz F., Baumann P., Manthey J., Hoffmann M., Schuler G., Mehmel H., Schmitz W., Kübler W. The effect of aortic valve replacement on survival. Circulation 1982, 66:1105-1110.
4. Kang D.H., Park S.J., Rim J.H., Yun S.C., Kim D.H., Song J.M., Choo S.J., Park S.W., Song J.K., Lee J.W., Park P.W. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010, 121:1502-1509.
5. Varadarajan P., Kapoor N., Bansal R.C., Pai R.G. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg 2006, 30:722-727.
6. Donnelly R., Millar-Craig M.W. Cardiac troponins: IT upgrade for the heart. Lancet 1998, 351:537-539.
7. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., Fischer G.A., Fung A.Y., Thompson C., Wybenga D., Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335:1342-1349.
8. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., Pagani F., Christenson R.H., Mockel M., Danne O., Jaffe A.S. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005, 51:810-824. Committee on Standardization of Markers of Cardiac Damage of the IFCC.
9. Aviles R., Askari A.T., Lindahl B., Wallentin L., Jia G., Ohman E.M., Mahaffey K.W., Newby L.K., Califf R.M., Simoons M.L., Topol E.J., Berger P., Lauer M.S. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002, 346:2047-2052.
10. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 2000, 343:1139-1147.
11. Eggers K.M., Lind L., Ahlström H., Bjerner T., Barbier C.E., Larsson A., Venge P., Lindahl B. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008, 29:2252-2258.
12. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., Angelici L., Barlera S., Parrinello G., Maggioni A.P., Tognoni G., Cohn J.N. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:242-249. Val-HeFT Investigators.
13. Schulz O., Paul-Walter C., Lehmann M., Abraham K., Berghöfer G., Schimke I., Jaffe A.S. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol 2007, 100:764-769.
14. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008, 52:450-459.
15. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., Tjora S., Domanski M.J., Gersh B.J., Rouleau J.L., Pfeffer M.A., Braunwald E. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547. Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators.
16. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., Seliger S.L. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
17. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998, 35:745-753.
18. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001, 24:613-634.
19. Teramoto T. Japan Atherosclerosis Society guidelines for prevention of atherosclerotic diseases in Japanese. Nihon Ronen Igakkai Zasshi 2008, 45:597-600.
20. Kosaka K. Diagnosis of diabetes mellitus. Nihon Naika Gakkai Zasshi 1982, 71:759-763.
21. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
22. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., Biedert S., Schaub N., Buerge C., Potocki M., Noveanu M., Breidthardt T., Twerenbold R., Winkler K., Bingisser R., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
23. Zähringer J., Klaubert A., Pritzl N., Stangl E., Kreuzer E. Gene expression in cardiac hypertrophy in rat and human heart muscle. Eur Heart J 1984, 5(Suppl. F):199-210.
24. Schwartzkopff B., Mundhenke M., Strauer B.E. Remodelling of intramyocardial arterioles and extracellular matrix in patients with arterial hypertension and impaired coronary reserve. Eur Heart J 1995, 16(Suppl. I):82-86.
25. Jin H., Lyon A.R., Akar F.G. Arrhythmia mechanisms in the failing heart. Pacing Clin Electrophysiol 2008, 31:1048-1056.
26. Krayenbuehl H.P., Hess O.M., Monrad E.S., Schneider J., Mall G., Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989, 79:744-755.
27. Dweck M.R., Joshi S., Murigu T., Alpendurada F., Jabbour A., Melina G., Banya W., Gulati A., Roussin I., Raza S., Prasad N.A., Wage R., Quarto C., Angeloni E., Refice S., et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011, 58:1271-1279.
28. Nojiri A., Hongo K., Kawai M., Komukai K., Sakuma T., Taniguchi I., Yoshimura M. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. J Cardiol 2011, 58:253-260.
29. Kitaoka H., Kubo T., Baba Y., Yamasaki N., Matsumura Y., Furuno T., Doi Y. Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy. J Cardiol 2012, 59:209-214.
30. Røsjø H., Andreassen J., Edvardsen T., Omland T. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol 2011, 108:88-91.